High Expression of ABCF1 is an Independent Predictor of Poor Prognosis in Bladder Cancer

Overview

Journal BMC Urol

Publisher Biomed Central

Specialty Urology

Date 2023 Mar 18

PMID 36932399

Authors

Jiawen Fan

Yi Ding

Haoxuan Huang

ShiDa Xiong

Liang He

Ju Guo

Affiliations

Soon will be listed here.

Abstract

ABCF1, a member of the ATP-binding cassette (ABC) transporter family, is involved in the malignant progression of tumors. However, the role of ABCF1 in bladder cancer is poorly understood. In our study, we explored the differential expression of ABCF1 in bladder cancer and normal bladder tissues based on bioinformatic analysis and immunohistochemical results. GSEA was performed to ascertain the potential related signaling pathways of ABCF1. The relationship between ABCF1 expression and bladder cancer progression was analyzed using the GSE13507 dataset. In addition, the differential expression of ABCF1 in the cell lines was verified by quantitative real-time polymerase chain reaction (qRT‒PCR) and Western blotting. ABCF1 was upregulated in bladder cancer, and the high expression of ABCF1 was closely related to sex (P = 0.00056), grade (P = 0.00049), T stage (P = 0.00007), and N stage (P = 0.0076). High expression of ABCF1 was correlated with poor overall survival in bladder cancer patients (P < 0.001). In addition, univariate and multivariate Cox regression analyses showed that high ABCF1 expression was an independent factor for poor prognosis in bladder cancer patients. Therefore, ABCF1 expression is closely related to the progression of bladder cancer and can be used as a potential indicator of poor prognosis and a therapeutic target for bladder cancer.

Citing Articles

DNA Sensor ABCF1 Phase Separates With cccDNA to Inhibit Hepatitis B Virus Replication.

Ren C, Zhang Z, Dou Y, Sun Y, Fu Z, Wang L Adv Sci (Weinh). 2024; 11(48):e2409485.

PMID: 39498874 PMC: 11672287. DOI: 10.1002/advs.202409485.

References

Lindqvist L, Vikstrom I, Chambers J, McArthur K, Ann Anderson M, Henley K . Translation inhibitors induce cell death by multiple mechanisms and Mcl-1 reduction is only a minor contributor. Cell Death Dis. 2012; 3:e409. PMC: 3481137. DOI: 10.1038/cddis.2012.149. View

Huang W, Li Y, Zhang C, Zha H, Zhou X, Fu B . IGF2BP3 facilitates cell proliferation and tumorigenesis via modulation of JAK/STAT signalling pathway in human bladder cancer. J Cell Mol Med. 2020; 24(23):13949-13960. PMC: 7753985. DOI: 10.1111/jcmm.16003. View

Matthews H, Bertoli C, de Bruin R . Cell cycle control in cancer. Nat Rev Mol Cell Biol. 2021; 23(1):74-88. DOI: 10.1038/s41580-021-00404-3. View

Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F . Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. Eur Urol. 2016; 71(1):96-108. DOI: 10.1016/j.eururo.2016.06.010. View

Kanehisa M . Toward understanding the origin and evolution of cellular organisms. Protein Sci. 2019; 28(11):1947-1951. PMC: 6798127. DOI: 10.1002/pro.3715. View

Kathawala R, Gupta P, Ashby Jr C, Chen Z . The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade. Drug Resist Updat. 2015; 18:1-17. DOI: 10.1016/j.drup.2014.11.002. View

Mughal M, Mahadevappa R, Kwok H . DNA replication licensing proteins: Saints and sinners in cancer. Semin Cancer Biol. 2018; 58:11-21. DOI: 10.1016/j.semcancer.2018.11.009. View

Vasiliou V, Vasiliou K, Nebert D . Human ATP-binding cassette (ABC) transporter family. Hum Genomics. 2009; 3(3):281-90. PMC: 2752038. DOI: 10.1186/1479-7364-3-3-281. View

Ye J, Chu C, Chen M, Shi Z, Gan S, Qu F . TROAP regulates prostate cancer progression via the WNT3/survivin signalling pathways. Oncol Rep. 2018; 41(2):1169-1179. DOI: 10.3892/or.2018.6854. View

10.

Lu Z, Song J, Sun T, Sun G . UBE2C affects breast cancer proliferation through the AKT/mTOR signaling pathway. Chin Med J (Engl). 2021; 134(20):2465-2474. PMC: 8654430. DOI: 10.1097/CM9.0000000000001708. View

11.

Bui Q, Hong J, Kwak M, Lee J, Lee P . Ubiquitin-Conjugating Enzymes in Cancer. Cells. 2021; 10(6). PMC: 8227520. DOI: 10.3390/cells10061383. View

12.

Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M . KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2022; 51(D1):D587-D592. PMC: 9825424. DOI: 10.1093/nar/gkac963. View

13.

Wang L, Yang C, Chu M, Wang Z, Xue B . Cdc20 induces the radioresistance of bladder cancer cells by targeting FoxO1 degradation. Cancer Lett. 2020; 500:172-181. DOI: 10.1016/j.canlet.2020.11.052. View

14.

Sun J, Huang J, Lan J, Zhou K, Gao Y, Song Z . Overexpression of CENPF correlates with poor prognosis and tumor bone metastasis in breast cancer. Cancer Cell Int. 2019; 19:264. PMC: 6788011. DOI: 10.1186/s12935-019-0986-8. View

15.

McCall K, Muccioli M, Benencia F . Toll-Like Receptors Signaling in the Tumor Microenvironment. Adv Exp Med Biol. 2020; 1223:81-97. DOI: 10.1007/978-3-030-35582-1_5. View

16.

Paytubi S, Wang X, Lam Y, Izquierdo L, Hunter M, Jan E . ABC50 promotes translation initiation in mammalian cells. J Biol Chem. 2009; 284(36):24061-73. PMC: 2782000. DOI: 10.1074/jbc.M109.031625. View

17.

Fung S, Cheung P, Yip C, Ng L, Cheung T, Chong C . The ATP-binding cassette transporter ABCF1 is a hepatic oncofetal protein that promotes chemoresistance, EMT and cancer stemness in hepatocellular carcinoma. Cancer Lett. 2019; 457:98-109. DOI: 10.1016/j.canlet.2019.05.010. View

18.

Zeng S, Liu A, Dai L, Yu X, Zhang Z, Xiong Q . Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms. BMC Cancer. 2019; 19(1):604. PMC: 6582551. DOI: 10.1186/s12885-019-5814-y. View

19.

Lee M, Roy M, Ong S, Mertins P, Villani A, Li W . Identification of regulators of the innate immune response to cytosolic DNA and retroviral infection by an integrative approach. Nat Immunol. 2012; 14(2):179-85. PMC: 3838897. DOI: 10.1038/ni.2509. View

20.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View